PetVivo Holdings, Inc. PETVW
0.03 USD 0.00 (+0.00%)
Jan 9, 2026, 3:54 PM EST
0.027 Day range 0.027
0.0285 52-week range 0.0285
- YTD
- -6.90%
- 1 year
- -6.90%
- Market cap
- 811.14K
- Revenue (ttm)
- 975.27K
- EPS (ttm)
- -0.86123
- P/E ratio
- -0.03
- YTD return
- -6.90%
- 1-year return
- -6.90%
- Volume
- 1.50K
- Avg volume
- 8.44K
- Open
- 0.027
- Previous close
- 0.027
- Day's range
- 0.027 – 0.027
- 52-week range
- 0.0285 – 0.0285
- Beta
- 2.55
No chart data for this range yet.
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.68
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 5.60%
- Free cash flow
- -3.86M
- Total cash
- 12.41K
- Total debt
- 1.17M
- Return on equity
- -1646.73%
- Short % of float
- 0.00%
- 50-day average
- 0.00
- 200-day average
- 0.00
Next earnings
Consensus EPS estimate 0.00.
About PetVivo Holdings, Inc.
PetVivo Holdings, Inc., a biomedical device company, manufactures, commercializes, and licenses medical devices and therapeutics for animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. is headquartered in Edina, Minnesota.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- petvivo.com
News
PETVIVO HOLDINGS ANNOUNCES TERMINATION AND SETTLEMENT AGREEMENT WITH VETSTEM 
PetVivo Reports Financial and Operational Results for Fiscal 2026 
PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE YEAR 2026 ENDED MARCH 31, 2026 
PetVivo Holdings, Inc. to Host Virtual Investor Event 
PetVivo Reports Results for Third Quarter and First Nine Months of Fiscal 2026
Your note
Sign in to keep a note on PETVW — it syncs with the Stock Master app.